Abstract:Objectives Hypertension is an important risk factor for the development of atherosclerosis. It is associated with an activated tissue rennin–angiotensin system. But the molecular mechanisms for this interaction are incompletely defined. To get insight into a role of the class A scavenger receptor (SR-A) in hypertension enhanced atherosclerotic complications, we have investigated the effects of angiotensin II (Ang II) on SR-A expression and macrophage foam cell formation in cultured human macrophages. Design and methods The human THP-1 monocyte cell line was differentiated into macrophages in vitro and treated with Ang II (10–10 and 10–6 M), or with Ang II (10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. SR-A message was measured by competitive reverse transcription-polymerase chain reaction (RT-PCR) and SR-A protein was detected by immunoblot. Results The human macrophages with various concentrations of Ang II enhanced, in a dose-and time-dependent manner, SR-A gene (3.4±0.8-fold by 10-6 M Ang II; P<0.05), and protein (2.8±0.4-fold; P<0.05) expression, reaching their maximum after 24 h incubation (14.3±1.5-fold for gene, P<0.05; 12.6±1.3-fold for protein, P<0.05, respectively); (2) The AT1 receptor blocker Irbesartan prevents these inductions; (3) The increased SR-A expression results in enhancement in the uptake of acetylated low-density lipoprotein (ac-LDL) by an AT1-dependent pathway; (4) Ang II induced human macrophage-derived foam cell formation through a SR-A-dependent pathway. Conclusions These results suggest that Ang II enhances SR-A expression in human macrophages, and that this effect is associated with foam cell formation. The induction of SR-A is mediated by the AT1 receptor. Some of the benefits of AT1 receptor blocker might be explained by their antiatherosclerotic reaction. Objectives Hypertension is an important risk factor for the development of atherosclerosis. It is associated with an activated tissue rennin–angiotensin system. But the molecular mechanisms for this interaction are incompletely defined. To get insight into a role of the class A scavenger receptor (SR-A) in hypertension enhanced atherosclerotic complications, we have investigated the effects of angiotensin II (Ang II) on SR-A expression and macrophage foam cell formation in cultured human macrophages. Design and methods The human THP-1 monocyte cell line was differentiated into macrophages in vitro and treated with Ang II (10–10 and 10–6 M), or with Ang II (10–8 M) and the angiotensin II type 1 (AT1) receptor blocker Irbesartan (10–5 M) for 24 h in the cells. Foam cell formation was quantified based on percentage of macrophage harboring oil red O-stained globules. SR-A message was measured by competitive reverse transcription-polymerase chain reaction (RT-PCR) and SR-A protein was detected by immunoblot. Results The human macrophages with various concentrations of Ang II enhanced, in a dose-and time-dependent manner, SR-A gene (3.4±0.8-fold by 10-6 M Ang II; P<0.05), and protein (2.8±0.4-fold; P<0.05) expression, reaching their maximum after 24 h incubation (14.3±1.5-fold for gene, P<0.05; 12.6±1.3-fold for protein, P<0.05, respectively); (2) The AT1 receptor blocker Irbesartan prevents these inductions; (3) The increased SR-A expression results in enhancement in the uptake of acetylated low-density lipoprotein (ac-LDL) by an AT1-dependent pathway; (4) Ang II induced human macrophage-derived foam cell formation through a SR-A-dependent pathway. Conclusions These results suggest that Ang II enhances SR-A expression in human macrophages, and that this effect is associated with foam cell formation. The induction of SR-A is mediated by the AT1 receptor. Some of the benefits of AT1 receptor blocker might be explained by their antiatherosclerotic reaction.

Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells.

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats

Angiotensin Ii Enhances Human Macrophage Class A Scavenger Receptor Expression And Induces Foam Cell Formation

Angiotensin-(1–7) Regulates Angiotensin II-induced VCAM-1 Expression on Vascular Endothelial Cells

Angiotensin Ii Upregulates Endothelial Lipase Expression Via The Nf-Kappa B And Mapk Signaling Pathways

Angiotensin Ii Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature - A Potential Link Between The Renin-Angiotensin System And Atherosclerosis

Class A scavenger receptor deficiency augments angiotensin II-induced vascular remodeling

[Angiotensin II Increases the Expression of Lectin-Like Oxidize Low-Density Lipoprotein Receptor- 1 in Cultured Human Umbilical Vein Endothlial Cells]

Expression Regulation and Signal Transduction of Scavenger Receptor Class B Type 1

Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs

Angiotensin II induces the expression of c-reactive protein via MAPK-dependent signal pathway in U937 macrophages.

DIFFERENT EFFECTS OF ANGIOTENSIN II AND ANGIOTENSIN-(1–7) ON ENDOTHELIAL VCAM-1 EXPRESSION DURING ATHEROSCLEROSIS

Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression in Rat Vasculature

Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells.

Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT1R Nox/ROS/PP2A Pathway

Abstract 624: Endothelial Scavenger Receptor Class B, Type I (SR-BI) Mediates LDL Uptake by the Artery Wall and Promotes Atherosclerosis in Hypercholesterolemic Mice

Angiotensin II Up-Regulates Soluble Epoxide Hydrolase in Vascular Endothelium in Vitro and in Vivo.

Abstract 2063: Endothelial Cell Scavenger Receptor Class B, Type I Expression is Transcriptionally Controlled by HIF-1α

Reactive oxygen species mediate angiotensin II-induced transcytosis of low-density lipoprotein across endothelial cells

EXP-2528, a Novel Angiotensin II Type 1 Receptor Antagonist, Protects Angiotensin II-stimulated Intercellular Adhesion Molecule-1 Via Nuclear Factor-Κb Activation in Brain Microvascular Endothelial Cells